MOF-coated upconversion nanoconstructs for synergetic photo-chemodynamic/oxygen-elevated photodynamic therapy

Excessive production of intracellular reactive oxygen species (ROS) can induce apoptosis of cancer cells; however, it is often limited by severe triggering conditions and hypoxic microenvironments of solid tumors. To address these issues, herein, we have designed a MOF-coated upconversion nanoconstruct (UCTSCF, referring to UC@Ce6/TFS@mSiO(2)@MIL-100(Cu/Fe)) for synergetic photochemodynamic therapy (PCT)/oxygen-elevated photodynamic therapy (PDT). The MOF (MIL-100(Fe)) coating with Cu-doping was designed to catalyze H2O2 overexpression in cancer cells to generate the most cytotoxic OH via chemodynamic therapy (CDT). It is noted that UC, representing 808 nm driven upconversion nanoparticles with high tissue penetration depth/low over-heating effects, was designed to provide intense blue light which can relieve the severe triggering conditions of CDT via PCT. Furthermore, the functional layer of the photosensitizer chlorin e6 (Ce6) and O-2-carrying triethoxy(1H,1H,2H,2H-nonafluorohexyl)silane (TFS) co-doped mesoporous silicon (Ce6/TFS@mSiO(2)) can cause oxygen-elevated O-1(2) production upon 671 nm light irradiation. In such a simple ROS generation nanoplatform, we heighten the antitumor effect via oxygen-elevated synergetic tumor PCT/PDT.

Automated summary

A MOF-coated upconversion nanoconstruct (UCTSCF) was designed for the treatment of hypoxic tumors. The MOF coating catalyzed the overexpression of H2O2 in cancer cells to generate cytotoxic reactive oxygen species, while the upconversion nanoparticles provided a light source to alleviate the severe treatment conditions. Additionally, the co-doped mesoporous silicon generated elevated oxygen levels, achieving synergetic photochemodynamic therapy/oxygen-elevated photodynamic therapy.